|
EXHIBIT 2.1
Execution
Copy
AGREEMENT AND PLAN OF
MERGER
AMONG
MIMEDX,
INC.
MMX ACQUISITION
CORP.
AND
ALYNX, CO.
DATED AS OF
JANUARY 29,
2008
|
|
|
|
|
|
ARTICLE I. ADOPTION OF
AGREEMENT
|
|
6 |
|
|
|
|
1.1
|
|
The
Merger
|
|
6 |
|
1.2
|
|
Effective
Date and Time of Merger
|
|
6 |
|
1.3
|
|
Surviving
Corporation
|
|
7 |
|
1.4
|
|
Effect of
Merger
|
|
7 |
|
1.5
|
|
Articles
of Incorporation of Surviving Corporation
|
|
7 |
|
1.6
|
|
Bylaws of
Surviving Corporation
|
|
7 |
|
1.7
|
|
Directors
and Officers of Surviving Corporation
|
|
7 |
|
|
|
ARTICLE II. PLAN OF MERGER
|
|
7 |
|
|
|
|
2.1
|
|
Conversion
|
|
7 |
|
2.2
|
|
Reservation of Shares for Target Warrants and Target
Options
|
|
10 |
|
2.3
|
|
Dissenter
Shareholders
|
|
10 |
|
2.4
|
|
Conversion
of Shares of Target Stock
|
|
11 |
|
2.5
|
|
Notice of
Change in Terms of Target Warrants and Options
|
|
12 |
|
2.6
|
|
Restricted
Stock
|
|
12 |
|
|
|
ARTICLE III. CLOSING
|
|
12 |
|
|
|
|
3.1
|
|
Closing
Date
|
|
12 |
|
3.2
|
|
Execution
of Merger Documents
|
|
12 |
|
|
|
ARTICLE IV. REPRESENTATIONS AND
WARRANTIES OF TARGET
|
|
12 |
|
|
|
|
4.1
|
|
Due
Incorporation; Foreign Qualification
|
|
13 |
|
4.2
|
|
Due
Authorization
|
|
13 |
|
4.3
|
|
Consents;
Non-Contravention.
|
|
13 |
|
4.4
|
|
Capitalization
|
|
14 |
|
4.5
|
|
Financial
Statements
|
|
14 |
|
4.6
|
|
No Adverse
Effect
|
|
15 |
|
4.7
|
|
Liabilities
|
|
15 |
|
4.8
|
|
Contracts
|
|
15 |
|
4.9
|
|
Tax
Matters
|
|
15 |
|
4.10
|
|
Reorganization Treatment
|
|
17 |
|
4.11
|
|
Environmental
|
|
17 |
|
4.12
|
|
Litigation
|
|
17 |
|
4.13
|
|
Conflict
of Interest
|
|
18 |
|
4.14
|
|
Compliance
with Laws
|
|
18 |
|
4.15
|
|
Broker
Fees
|
|
18 |
|
4.16
|
|
Board
Approval
|
|
18 |
|
4.17
|
|
Target
Party Disclosure Documents
|
|
18 |
|
4.18
|
|
Full
Disclosure
|
|
19 |
|
4.19
|
|
Title to
Properties
|
|
19 |
|
|
|
ARTICLE V. REPRESENTATIONS OF ALYNX AND
MERGER SUB
|
|
19 |
|
|
|
|
5.1
|
|
Due
Incorporation; Foreign Qualification
|
|
19 |
ii
|
|
|
|
|
|
5.2
|
|
Due
Authorization
|
|
20 |
|
5.3
|
|
Non-Contravention
|
|
20 |
|
5.4
|
|
Capitalization
|
|
21 |
|
5.5
|
|
Financial
Statements
|
|
21 |
|
5.6
|
|
No Adverse
Effect
|
|
22 |
|
5.7
|
|
Title to
Properties
|
|
22 |
|
5.8
|
|
Liabilities
|
|
22 |
|
5.9
|
|
Contracts
|
|
22 |
|
5.10
|
|
Insurance
|
|
22 |
|
5.11
|
|
Employee
Benefit Plans
|
|
22 |
|
5.12
|
|
Tax
Matters
|
|
22 |
|
5.13
|
|
Reorganization Treatment
|
|
24 |
|
5.14
|
|
Environmental
|
|
25 |
|
5.15
|
|
Litigation
|
|
25 |
|
5.16
|
|
Conflict
of Interest
|
|
25 |
|
5.17
|
|
Bank
Accounts
|
|
25 |
|
5.18
|
|
Compliance
with Laws
|
|
25 |
|
5.19
|
|
Broker
Fees
|
|
25 |
|
5.20
|
|
Board
Approval
|
|
26 |
|
5.21
|
|
SEC
Filings
|
|
26 |
|
5.22
|
|
Takeover
Restrictions
|
|
26 |
|
5.23
|
|
Officer,
Director and Promoter’s Information
|
|
26 |
|
5.24
|
|
Full
Disclosure
|
|
27 |
|
|
|
ARTICLE VI. COVENANTS
|
|
27 |
|
|
|
|
6.1
|
|
Implementing Agreement
|
|
27 |
|
6.2
|
|
Access to
Information and Facilities; Confidentiality
|
|
27 |
|
6.3
|
|
Preservation of Business
|
|
27 |
|
6.4
|
|
Certain
Notices
|
|
29 |
|
6.5
|
|
Blue Sky
Compliance
|
|
29 |
|
6.6
|
|
Post-Merger Board Composition and Officers
|
|
29 |
|
6.7
|
|
Issuance
of Shares as Finder’s Fee
|
|
29 |
|
6.8
|
|
Consents
and Approvals
|
|
29 |
|
6.9
|
|
Maintenance of Insurance
|
|
30 |
|
6.10
|
|
No Other
Negotiations
|
|
30 |
|
6.11
|
|
Shareholder Meeting
|
|
30 |
|
6.12
|
|
Schedules
|
|
30 |
|
6.13
|
|
Supplemental Information
|
|
30 |
|
6.14
|
|
Tax-Free
Reorganization Treatment
|
|
31 |
|
6.15
|
|
Compliance
with Rule 14f-1
|
|
31 |
|
6.16
|
|
Registration Rights Agreement
|
|
31 |
|
|
|
ARTICLE VII. CONDITIONS PRECEDENT TO
OBLIGATIONS OF ALYNX
|
|
31 |
|
|
|
|
7.1
|
|
Representations and Warranties
|
|
31 |
|
7.2
|
|
Compliance
with Agreements and Covenants
|
|
31 |
|
7.3
|
|
Consents
and Approvals
|
|
31 |
iii
|
|
|
|
|
|
7.4
|
|
Documents
|
|
32 |
|
7.5
|
|
No
Material Adverse Change
|
|
32 |
|
7.6
|
|
Actions or
Proceedings
|
|
32 |
|
7.7
|
|
Target
Dissenting Shareholders
|
|
32 |
|
7.8
|
|
Approval
of Merger
|
|
32 |
|
7.9
|
|
No
Registration
|
|
32 |
|
7.10
|
|
Form
8-K
|
|
32 |
|
|
|
ARTICLE VIII. CONDITIONS PRECEDENT TO
OBLIGATIONS OF TARGET
|
|
32 |
|
|
|
|
8.1
|
|
Representations and Warranties
|
|
32 |
|
8.2
|
|
Compliance
with Agreements and Covenants
|
|
33 |
|
8.3
|
|
Shareholder Approval and Other Consents and
Approvals
|
|
33 |
|
8.4
|
|
Documents
|
|
33 |
|
8.5
|
|
No
Material Adverse Change
|
|
33 |
|
8.6
|
|
Actions or
Proceedings
|
|
33 |
|
8.7
|
|
Target
Dissenting Shareholders
|
|
33 |
|
8.8
|
|
No
Registration
|
|
33 |
|
8.9
|
|
Alynx
Indebtedness
|
|
33 |
|
8.10
|
|
Filing of
SEC Reports
|
|
33 |
|
8.11
|
|
No
Shareholder Vote of Alynx Required
|
|
33 |
|
8.12
|
|
Form
8-K
|
|
34 |
|
8.13
|
|
Certificate of Designation
|
|
34 |
|
|
|
ARTICLE IX. DELIVERIES AT
CLOSING
|
|
34 |
|
|
|
|
9.1
|
|
Target
Closing Deliveries
|
|
34 |
|
9.2
|
|
Alynx
Closing Deliveries
|
|
34 |
|
|
|
ARTICLE X. TERMINATION
|
|
35 |
|
|
|
|
10.1
|
|
Merger
Agreement Termination
|
|
35 |
|
10.2
|
|
Effect of
Termination
|
|
36 |
|
|
|
ARTICLE XI. MISCELLANEOUS
|
|
37 |
|
|
|
|
11.1
|
|
Certain
Definitions
|
|
37 |
|
11.2
|
|
Other
Definitions
|
|
39 |
|
11.3
|
|
Expenses
|
|
40 |
|
11.4
|
|
Amendment
|
|
40 |
|
11.5
|
|
Non-Survival of Representation and Warranty Breach
|
|
40 |
|
11.6
|
|
Press
Release; Public Announcements
|
|
40 |
|
11.7
|
|
Notices
|
|
40 |
|
11.8
|
|
Waivers
|
|
41 |
|
11.9
|
|
Interpretation
|
|
41 |
|
11.10
|
|
Applicable
Law
|
|
41 |
|
11.11
|
|
Assignment
|
|
42 |
|
11.12
|
|
No Third
Party Beneficiaries
|
|
42 |
|
11.13
|
|
Further
Assurances
|
|
42 |
iv
|
|
|
|
|
|
11.14
|
|
Severability
|
|
42 |
|
11.15
|
|
Remedies
Cumulative
|
|
42 |
|
11.16
|
|
Entire
Understanding
|
|
42 |
|
11.17
|
|
Counterparts
|
|
42 |
|
|
|
SCHEDULES AND EXHIBITS
|
|
|
|
|
|
SCHEDULE 4.8
|
|
|
|
SCHEDULE 4.15
|
|
|
|
SCHEDULE 5.9
|
|
|
|
SCHEDULE 5.10
|
|
|
|
SCHEDULE 5.19
|
|
|
|
SCHEDULE 6.16
|
|
|
|
|
|
EXHIBIT 1.2
|
|
|
|
EXHIBIT 2.1(a)
|
|
|
|
EXHIBIT 6.16
|
|
|
v
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN
OF MERGER (this “ Agreement ”) dated as of
January 29, 2008, by and among MiMedx, Inc., a Florida
corporation (the “ Target ”), Alynx, Co., a
Nevada corporation (“ Alynx ”), and MMX
Acquisition Corp., a Florida corporation and wholly-owned
subsidiary of Alynx (the “ Merger Sub ”).
Certain capitalized terms used in this Agreement are defined in
ARTICLE XI of this Agreement.
W I T N E S S E T H :
WHEREAS, Alynx
desires to acquire Target, and Target desires to be acquired by
Alynx through the merger of Merger Sub with and into Target, with
Target being the surviving entity pursuant to the terms hereinafter
set forth (the “ Merger ”);
WHEREAS, the
respective Boards of Directors of Alynx, Merger Sub, and Target
have approved and declared advisable the Merger upon the terms and
subject to the conditions of this Agreement, and in accordance with
Nevada Corporation Law in the case of Alynx and the Florida
Business Corporation Act (as amended, the “ Florida
Act ”) in the case of Merger Sub and Target;
WHEREAS, the
respective Boards of Directors of Alynx, Merger Sub, and Target
have determined that the Merger is in furtherance of and consistent
with their respective business strategies and is in the best
interest of their respective shareholders, and Alynx, as the sole
shareholder of Merger Sub, has approved this Agreement and the
Merger, and the holders of Target Stock (as defined below) will
hold a meeting to approve this Agreement and the Merger prior to
the Closing; and
WHEREAS, Alynx,
Merger Sub, and Target each intends, for federal income tax
purposes, that the Merger contemplated hereby constitute a
reorganization pursuant to Section 368(a)(1)(A) of the
Internal Revenue Code of 1986, as amended (the “ Code
”).
NOW, THEREFORE, in
consideration of the premises and the mutual covenants and
agreements hereinafter contained, the parties hereto, intending to
be legally bound hereby, agree as follows:
ARTICLE I.
ADOPTION OF
AGREEMENT
1.1 The
Merger . Upon the terms and subject to the satisfaction or
waiver of the conditions set forth in this Agreement, at the
Effective Time (as defined in Section 1.2 herein), in
accordance with the relevant provisions of the Florida Act, Merger
Sub shall be merged with and into Target, and Target shall be the
surviving corporation of the Merger (the “ Surviving
Corporation ”). Upon completion of the Merger, the
existence of Merger Sub shall cease at the Effective Time as a
consequence of the Merger.
1.2 Effective
Date and Time of Merger . Upon the terms and subject to the
conditions hereof, as soon as practicable after the satisfaction or
waiver of the conditions set forth in ARTICLE VII and ARTICLE VIII
of this Agreement, Articles of Merger substantially in
the
form annexed hereto as
EXHIBIT 1.2 (the “ Articles of Merger ”)
shall be executed and delivered to the Department of State of the
State of Florida in accordance with Section 607.1105 of the
Florida Act (the time of such filing being the “ Effective
Time ”, and the date of such filing being the “
Effective Date ”).
1.3 Surviving
Corporation . Following the Merger, Target shall continue to
exist under and be governed by the laws of the State of Florida and
shall be the Surviving Corporation.
1.4 Effect of
Merger . At the Effective Time, the effect of the Merger shall
be as provided in the applicable provisions of the Florida Act.
Without limiting the generality of the foregoing, at the Effective
Time, all the property, rights, privileges, powers, and franchises
of the Target and the Merger Sub shall vest in the Surviving
Corporation.
1.5 Articles of
Incorporation of Surviving Corporation . The Articles of
Incorporation of Target, as in effect at the Effective Time, shall
continue in full force and effect, and shall be the Articles of
Incorporation of the Surviving Corporation.
1.6 Bylaws of
Surviving Corporation . The Bylaws of Target, as in effect at
the Effective Time, shall continue in full force and effect, and
shall be the Bylaws of the Surviving Corporation.
1.7 Directors
and Officers of Surviving Corporation . The directors of Target
immediately prior to the Effective Time shall be the initial
directors of the Surviving Corporation, each to hold office in
accordance with the Articles of Incorporation and Bylaws of the
Surviving Corporation. The officers of Target immediately prior to
the Effective Time shall be the initial officers of the Surviving
Corporation, each to hold office in accordance with the Articles of
Incorporation and Bylaws of the Surviving Corporation.
ARTICLE II.
PLAN OF
MERGER
2.1
Conversion .
(a) Conversion
of Target Stock . Subject to the provisions of Sections 2.1(e),
and (f) and Section 2.3 hereof, at the Effective
Time:
(i) each
share of Common Stock, par value $.0001 per share, of Target (the
“ Target Common Stock ”), issued and outstanding
immediately prior to the Effective Time shall be converted into the
right to receive 3.091421 shares of Common Stock, par value $.001
per share, of Alynx (the “ Alynx Common Stock ”)
(such conversion rate is hereinafter referred to as the “
Common Conversion Rate ”); and
(ii) each
share of Series A Preferred Stock, Series B Preferred Stock, and
Series C Preferred Stock, each par value $.0001 per share, of
Target (the “ Target Preferred Stock ”; and,
together with the Target Common Stock, the “ Target
Stock ”), issued and outstanding immediately prior to the
Effective Time shall be converted into the right to receive .20
shares of Series A Preferred Stock, par
value $.001 per
share of Alynx, having the rights, preferences, and designations
set forth on the Certificate of Designation attached hereto as
EXHIBIT 2.1(a) and incorporated herein by reference (the
“ Alynx Preferred Stock ” and such conversion
rate is hereinafter referred to as the “ Preferred
Conversion Rate ”).
All of the shares of Alynx
Common Stock issued pursuant to such conversion (including any
shares that would have been issued except for the provisions of
Sections 2.1(g) and 2.3), together with (x) all shares of
Alynx Common Stock issuable upon exercise of the Target Options and
Target Warrants and (y) all shares of Alynx Common Stock
issuable upon conversion of the Alynx Preferred Stock, shall equal,
as near as practicable, approximately ninety-seven percent
(97%) of Alynx’s issued and outstanding shares of Common
Stock immediately after the Effective Time, calculated without
regard to any limitation in the number of shares of Alynx Common
Stock authorized by its Articles of Incorporation.
All converted shares of
Target Stock shall no longer be outstanding and shall automatically
be canceled and retired and shall cease to exist, and each
certificate previously representing any such converted shares shall
thereafter represent the right to receive a certificate (or
electronic register) representing that number of shares of Alynx
Common Stock or Alynx Preferred Stock (collectively “
Alynx Stock ”) into which such shares of Target Stock
were converted in the Merger pursuant to this Agreement.
(b) Conversion
of Target Warrants . At the Effective Time, each issued and
outstanding warrant to purchase shares of capital stock of Target
at the Effective Time (the “ Target Warrants ”),
by virtue of the terms thereof and the Merger and without further
action, shall be assumed by Alynx and modified so that, in lieu of
having the right to acquire such shares of capital stock of Target
on exercise of the applicable Target Warrant, the holders thereof
shall have the right to acquire that number of shares of Alynx
Common Stock equal to (i) that number of shares of Target
Stock as have been set forth in the applicable Target Warrant,
multiplied by (ii) the Common Conversion Rate. The per
share exercise price for the shares of Alynx Common Stock issuable
upon exercise of each such assumed Target Warrant shall be equal to
the quotient determined by dividing (x) the exercise price per
share of Target Stock at which such Target Warrant was exercisable
immediately prior to the Effective Time by (y) the Common
Conversion Rate, rounded up to the nearest whole cent.
(c) Conversion
of Target Options . At the Effective Time, all unexercised and
unexpired options to purchase shares of Target Stock then
outstanding under any stock option plan of Target at the Effective
Time, including the MiMedx, Inc. 2006 Stock Incentive Plan, the
MiMedx, Inc. Assumed 2005 Stock Incentive Plan (formerly the
SpineMedica Corp. 2005 Stock Incentive Plan), and the MiMedx, Inc.
Assumed 2007 Stock Incentive Plan (formerly the SpineMedica Corp.
2007 Stock Incentive Plan), or any other plan, agreement, or
arrangement (the “ Target Stock Option Plans ”),
whether or not then exercisable (the “ Target Options
”), shall be assumed by Alynx. Each Target Option so assumed
by Alynx under this Agreement shall continue to have, and be
subject to, the same terms and conditions as set forth in the
applicable Target Stock Option Plan and any agreements thereunder
immediately prior to the Effective Time (including, without
limitation, the vesting schedule (without acceleration thereof by
virtue of the Merger and the transactions contemplated hereby)),
except that: (i) each Target Option shall be exercisable (or
shall become exercisable in accordance with its terms) for that
number of whole shares of Alynx Common Stock equal to (A) the
number of shares of Target
Stock issuable upon the
exercise of such Target Option immediately prior to the Effective
Time, multiplied by (B) the Common Conversion Rate; and
(ii) the per share exercise price for the shares of Alynx
Common Stock issuable upon exercise of each such assumed Target
Option shall be equal to the quotient determined by dividing
(X) the exercise price per share of Target Stock at which such
Target Option was exercisable immediately prior to the Effective
Time by (Y) the Common Conversion Rate, rounded up to the
nearest whole cent. The conversion of any Target Options which are
“incentive stock options” within the meaning of
Section 422 of the Code into options to purchase Alynx Common
Stock shall be made in a manner consistent with Section 424(a)
of the Code so as not to constitute a “modification” of
such Target Options within the meaning of Section 424 of the
Code. Continuous employment with Target or its subsidiaries shall
be credited to the optionee for purposes of determining the vesting
of all assumed Target Options after the Effective Time.
(d) Merger
Sub . Each share of common stock, par value $0.0001 per share,
of Merger Sub issued and outstanding immediately prior to the
Effective Time shall be converted into and be exchanged for one
(1) newly and validly issued, fully paid and nonassessable
share of common stock, par value $0.0001 per share, of the
Surviving Corporation.
(e) Equitable
Adjustments . If during the period between the date of this
Agreement and the Effective Time the outstanding shares of Alynx
Stock or Target Stock shall have been changed into a different
number of shares or a different class, by reason of any stock
dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares, then the Conversion Rate shall
be correspondingly and equitably adjusted to reflect such stock
dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares.
(f) Fractional
Shares . As a result of the application of the Common
Conversion Rate, the holders of Target Common Stock will receive
fractional shares of Alynx Common Stock in connection with the
Merger. It is contemplated that after the Merger, and subject to
the approval of the shareholders of Alynx, Alynx will accomplish a
reverse stock split (the “ Proposed Stock Split
”), which shall eliminate such fractional shares and result
in the current holders of Target Common Stock owning the same
number of shares of Alynx Common Stock as such shareholder owned in
the Target immediately prior to the Merger.
(g) Cash
Consideration in Limited Circumstances . After the Effective
Time, each share of capital stock which previously represented an
outstanding share of Target Stock, and which is held by (i) an
“accredited investor” (as defined in Rule 501 of
Regulation D, promulgated by the SEC under the Securities Act) or
(ii) a person who does not qualify as an accredited investor,
but who, either alone or together with such person’s
purchaser representative, has such knowledge and experience in
financial and business matters that such person is capable of
evaluating the merits and risks of an investment in Alynx Stock and
can bear the economic risk of such an investment, shall be
converted into the right to receive Alynx Stock as provided in
Section 2.1(a). Notwithstanding anything herein to the
contrary, if a former holder of Target Stock does not demonstrate
to Alynx, in its sole discretion, that such person meets one of the
two tests provided for in clauses (i) and (ii) in the
preceding sentence, Alynx may elect, in its sole discretion, to
cause the Surviving Corporation to pay the fair market value as of
the Effective Time, as determined in the reasonable discretion of
the Board of
Directors of Alynx, for each
share of Target Stock previously held by that person (each, a
“ Target Non-Accredited Shareholder ”) in lieu
of Alynx Stock.
(h) Cash
Dividend to Alynx .
(i)
Immediately following the Effective Time, Target will pay a cash
dividend in the amount of $250,000 to Alynx , which funds
will be used as follows:
(x) first, to
the payment in full of the convertible promissory notes (the
“ Convertible Promissory Notes ”) in the
aggregate amount of $10,000, plus interest and any fees or
penalties;
(y) then, to
the payment in full of the promissory notes to the president of
Alynx and the payment of all other outstanding payables,
liabilities and expenses of Alynx, including all expenses incurred
in connection with the Merger and the transactions contemplated by
this Agreement; and
(z) the
remainder shall be paid to Ken Edwards as full consideration for
the redemption and cancellation of 20,000,000 shares of Alynx
Common Stock.
(ii)
Immediately following the Effective Time, Target shall cause to be
deposited into the client trust account of counsel for Alynx the
$250,000 cash dividend referenced in Section 2.1(h)(i) above
with irrevocable instructions mutually agreeable to Alynx and
Target to distribute such funds as provided in Sections
2.1(h)(i)(x), 2.1(h)(i)(y), and 2.1(h)(i)(z) above.
(i) Assumption
of Registration Rights Agreement . At the Effective Time, Alynx
shall assume and agree to satisfy, discharge and perform in due
course all of Target’s obligations under the Amended and
Restated Registration Rights Agreement dated July 23, 2007 by
and between the Target and the holders of the Target Preferred
Stock.
2.2 Reservation
of Shares for Target Warrants and Target Options . Alynx shall
retain and reserve that number of authorized but unissued shares of
Alynx Common Stock that shall be issuable upon the exercise of the
Target Warrants and the Target Options at any given time until
their respective exercise, conversion, or termination, as
applicable, subject to the maximum number of shares authorized to
be issued by Alynx.
2.3 Dissenter
Shareholders . Any holder of shares of Target Stock issued and
outstanding immediately prior to the Effective Time, with respect
to which dissenters’ rights, if any, are available by reason
of the Merger pursuant to Section 607.1302 of the Florida Act,
who has not voted in favor of the Merger or consented thereto in
writing and who complies with the requirements of
Section 607.1300 et seq. of the Florida Act (the “
Target Dissenting Shares ”) shall not be entitled to
receive any Alynx Stock pursuant to this ARTICLE II, unless such
holder (the “ Target Dissenting Shareholder(s)
”) fails to perfect, effectively withdraws or loses its
dissenters’ rights under the Florida Act. Each Target
Dissenting Shareholder shall be entitled to receive only such
rights as are granted under Section 607.1300 et seq. of the
Florida
Act. If any Target Dissenting
Shareholder fails to perfect, effectively withdraws or loses such
dissenters’ rights under the Florida Act, such holder shall
no longer be deemed a Target Dissenting Shareholder and such
holder’s Target Dissenting Shares shall thereupon be deemed
to have been converted as of the Effective Time into the right to
receive that class and number of shares of Alynx Stock to which
such shares of Target Stock are entitled pursuant to this ARTICLE
II, in each case without interest. Prior to the Effective Time,
Target shall give Alynx prompt notice of any written demands for
appraisal pursuant to Section 607.1321 of the Florida Act
received by Target, withdrawals of any such written demands and any
other documents or instruments received by Target in connection
therewith. Prior to the Effective Time, Target shall not, except
with the prior written consent of Alynx, which consent shall not
unreasonably be withheld or delayed, make any payment with respect
to, or settle or offer to settle, any such demands, or agree to do
any of the foregoing. Any payments made with respect to Target
Dissenting Shares shall be made solely by the Surviving
Corporation, and no funds or other property shall be provided by
Target, Alynx or Merger Sub for such payment.
2.4 Conversion
of Shares of Target Stock . The manner of converting shares of
Target Stock into shares of Alynx Stock in accordance with ARTICLE
II above shall be as follows:
(a) From and after
the Effective Time, Alynx (either directly or through its transfer
agent) shall act as exchange agent in effecting the conversion of
certificates representing shares of Target Stock pursuant to
Section 2.1(a) hereof. Alynx will record and maintain an
electronic register of the shares of Alynx Stock issued to each
holder of shares of Target Stock other than a Target Dissenting
Shareholder or a Target Non-Accredited Shareholder (each, a “
Participating Shareholder ”) in connection with the
Merger. After the Proposed Stock Split is completed, or at such
earlier time as the Alynx Stock issued in the Merger may be freely
sold under applicable securities laws, Alynx (either directly or
through its transfer agent) shall cause certificates representing
shares of Alynx Stock to be distributed to each Participating
Shareholder who has surrendered to Alynx certificates which prior
to the Effective Time represented shares of Target Stock, all in
accordance with the provisions of this ARTICLE II. Upon the
surrender by Participating Shareholders, the certificates which
prior to the Effective Time represented outstanding shares of
Target Stock shall forthwith be canceled. Until so surrendered and
exchanged, each such certificate representing shares of Target
Stock shall be deemed for all purposes to evidence only a right to
receive shares of Alynx Stock as provided herein, and the holders
of such certificates after the Effective Time shall no longer be
deemed for any purpose to be holders of shares of Target Stock or
the Surviving Corporation.
(b) Participating
Shareholders shall, for all purposes (except for the payment of
possible dividends or other distributions by Alynx which shall be
withheld until the exchange of certificates pursuant to
Section 2.4(a) hereof), be deemed to be shareholders of Alynx,
as of the Effective Time, irrespective of whether they have
received their certificates representing shares of Alynx
Stock.
(c) Promptly after
the Effective Time, Alynx (either directly or through its transfer
agent), on behalf of the Surviving Corporation and Alynx, shall
cause to be mailed to each holder of record of certificates which
immediately prior to the Effective Time represented shares of
Target Stock a form of letter of transmittal and instructions for
use in surrendering such certificates and (i) with respect to
a Participating Shareholder, receiving certificates
representing shares of Alynx
Stock, or (ii) with respect to a Target Non-Accredited
Shareholder or a Target Dissenting Shareholder, receiving such
consideration as provided for in Section 2.1(g) and 2.3,
respectively.
2.5 Notice of
Change in Terms of Target Warrants and Options . Promptly after
the Effective Time, Alynx shall mail to each holder of Target
Warrants and Target Options a notice of the terms of their
respective securities as a result of the Merger.
2.6 Restricted
Stock . The Alynx Stock to be issued pursuant to the Merger
shall not have been registered and shall be characterized as
“restricted securities” under the federal securities
laws, and under such laws such shares may be resold without
registration under the Securities Act only in certain limited
circumstances. Each certificate evidencing Alynx Stock to be issued
pursuant to the Merger shall bear the following legend:
THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT
AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE
SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD OR OTHERWISE
TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION WITHOUT AN
EXEMPTION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES
LAWS OR AN OPINION OF THE COMPANY’S LEGAL COUNSEL THAT SUCH
REGISTRATION IS NOT REQUIRED.
ARTICLE
III.
CLOSING
3.1 Closing
Date . Immediately following the Effective Time, the closing of
the Merger and the consummation of the other transactions
contemplated by this Agreement (the “ Closing ”)
shall take place at the offices of Womble Carlyle
Sandridge & Rice, PLLC, 1201 West Peachtree Street, Suite
3500, Atlanta, Georgia 30309 at 5:00 p.m., eastern time, on
February 8, 2008 or as soon as practicable after the
satisfaction or waiver of the conditions set forth in ARTICLE VII
and ARTICLE VIII of this Agreement, or such other date, time and
place as each of the parties hereto may otherwise agree in writing
(the “ Closing Date ”).
3.2 Execution of
Merger Documents . On the Closing Date, the parties hereto
shall cause the Merger to be consummated by filing the Articles of
Merger, together with any required, related certificates, with the
Department of State of the State of Florida, in such form as
required by, and executed in accordance with the relevant
provisions of, the Florida Act. The Merger shall be effective as of
the Effective Time.
ARTICLE IV.
REPRESENTATIONS AND
WARRANTIES OF TARGET
Target represents and
warrants to Alynx that all of the statements contained in this
ARTICLE IV are true as of the date of this Agreement (or, if made
as of a specified date, as of such date)
except, in each case, as
(a) set forth in the schedules attached to this Agreement (the
“ Disclosure Schedules ”); or (b) as
otherwise provided in this Agreement. For purposes of the
representations and warranties of Target contained in this ARTICLE
IV, disclosure in any section of the Disclosure Schedules of any
facts or circumstances shall be deemed to be an adequate response
and disclosure of such facts or circumstances with respect to all
representations or warranties by Target calling for disclosure of
such information, whether or not such disclosure is specifically
associated with or purports to respond to one or more or all of
such representations or warranties, if it is reasonably apparent on
the face of the Disclosure Schedules that such disclosure is
applicable. The inclusion of any information in any section of the
Disclosure Schedules by Target shall not be deemed to be an
admission or evidence of materiality of such item, nor shall it
establish a standard of materiality for any purpose
whatsoever.
4.1 Due
Incorporation; Foreign Qualification .
(a) Target is a
corporation and SpineMedica is a limited liability company, each
duly organized, validly existing and in good standing under the
laws of the State of Florida, with all requisite power and
authority to own, lease and operate its properties and to carry on
its business as it is now being owned, leased, operated and
conducted. To the Knowledge of Target, each Target Party is
qualified or licensed to do business and is in good standing as a
foreign company in each jurisdiction where the nature of the
properties owned, leased or operated by it and the business
transacted by it requires such qualification or licensing, except
where the failure to be so qualified or licensed and in good
standing would not, individually or in the aggregate, have a Target
Material Adverse Effect. True, correct and complete copies of the
Articles of Incorporation and Bylaws or other applicable
organizational documentation of each of the Target Parties, each as
amended or restated as of the date hereof, have been, or prior to
the Closing Date shall have been, delivered to Alynx. Except for
the ownership by Target of all of the membership interests in
SpineMedica, neither of the Target Parties has any wholly or
partially owned subsidiaries, or owns any economic, voting or
management interests in any other Person.
4.2 Due
Authorization . Subject to the Shareholder Approval, Target has
full power and authority to enter into this Agreement, the Articles
of Merger and to consummate the transactions contemplated hereby
and thereby. The execution, delivery and performance by Target of
this Agreement have been duly and validly approved and authorized
by the Board of Directors of Target, and, other than the
Shareholder Approval, no other actions or proceedings on the part
of Target are necessary to authorize this Agreement, the Articles
of Merger and the transactions contemplated hereby and thereby.
Target has duly and validly executed and delivered this Agreement.
This Agreement constitutes the legal, valid and binding obligation
of Target, enforceable in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency,
fraudulent transfer, moratorium, reorganization or other laws from
time to time in effect which affect creditors’ rights
generally and by general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity
or at law).
4.3 Consents;
Non-Contravention .
(a) Except for the
filing of the Articles of Merger with the appropriate authorities
pursuant to the Florida Act, filings required by applicable federal
and state securities
laws, and the requirement to
obtain Shareholder Approval, no permit, consent, authorization or
approval of, or filing or registration with, any Governmental
Authority or any other Person not a party to this Agreement, is
necessary in connection with the execution, delivery and
performance by Target of this Agreement or the Articles of Merger,
or the consummation of the transactions contemplated hereby or
thereby, or for the lawful continued operation by Alynx following
the Effective Time of the respective businesses currently conducted
by the Target Parties.
(b) Except as would
not result in a Target Material Adverse Effect, the execution,
delivery and performance by Target of this Agreement and the
Articles of Merger do not and will not (i) violate any Law;
(ii) violate or conflict with, result in a breach or
termination of, or constitute a default (or a circumstance which,
with or without notice or lapse of time or both, would constitute a
default) under any Target Material Contract; (iii) give any
third party any additional right (including a termination right)
under, permit cancellation of, or result in the creation of any
Lien (except for any Lien for taxes not yet due and payable) upon
any of the assets or properties of any Target Party under any
Contract to which any Target Party is a party or by which any
Target Party or any of their respective assets or properties are
bound; (iv) permit the acceleration of the maturity of any
indebtedness of any Target Party or indebtedness secured by any
Target Party’s assets or properties; (v) violate or
conflict with any provision of the Articles of Incorporation or
Bylaws of Target; or (vi) result in the activation of any
anti-dilution rights or a reset or repricing of any debt or
security instrument of any creditor or equity holder of any Target
Party except as provided for in this Agreement.
4.4
Capitalization . The authorized capital stock of Target
consists of 60,000,000 shares of Target Common Stock and 25,000,000
shares of Target Preferred Stock, of which 11,250,000 shares are
designated Series A Preferred Stock, 6,000,000 shares are
designated Series B Preferred Stock and 2,000,000 shares are
designated Series C Preferred Stock. On the date hereof, there are
issued and outstanding 16,912,317 shares of Target Common Stock,
11,212,800 shares of Series A Preferred Stock, 5,922,398 shares of
Series B Preferred Stock, 1,285,001 shares of Series C Preferred
Stock, 3,958,750 Target Options, and 709,331 Target Warrants. All
of the issued and outstanding shares of Target Stock are validly
issued, fully paid and non-assessable and the issuance thereof was
not subject to preemptive rights or was issued in compliance
therewith. Target is the sole member of, and the beneficial and
record owner of all issued and outstanding membership interests in,
SpineMedica.
4.5 Financial
Statements . The Target Financial Statements have been
delivered to Alynx. The Target Financial Statements have been
prepared from, are in accordance with and accurately reflect the
books and records of the respective Target Parties and have been
prepared in accordance with GAAP applied on a consistent basis
during the periods involved (except as may be stated in the notes
thereto and provided that the unaudited Target Financial Statements
do not reflect year-end closing adjustments and procedures and do
not contain explanatory notes) and present fairly, in all material
respects, the consolidated financial position, results of
operations and cash flows as of the times and for the periods
covered therein. The Target Financial Statements do not reflect any
transactions which are not bona fide transactions and do not
contain any untrue statement of a material fact or omit to state
any material fact necessary to make the statements contained
therein, in light of the circumstances in which they were made, not
misleading. The Target Financial Statements make full and adequate
disclosure of, and provision for, all material obligations and
liabilities of the respective Target Parties as of the
date
thereof. There are no
significant deficiencies or material weaknesses in the design or
operation of any Target Party’s internal controls which would
adversely affect such Target Party’s ability to record,
process, summarize and report financial data.
4.6 No Adverse
Effect . Since the date of the Target Financial Statements,
neither Target Party has suffered any Target Material Adverse
Effect.
4.7
Liabilities . Except to the extent reflected in the Target
Financial Statements, neither Target Party has any material debts,
liabilities or obligations of any nature other than debts,
liabilities or obligations incurred subsequent to the date of the
Target Financial Statements in the ordinary course of
business.
4.8
Contracts . SCHEDULE 4.8 lists all the Target
Material Contracts. Target has made available to Alynx true and
complete copies of each Target Material Contract and a written
description of each oral arrangement constituting a Target Material
Contract.
4.9 Tax
Matters .
(a) “
Taxes ”, as used in this Agreement, means any federal,
state, county, local or foreign taxes, charges, fees, levies, or
other assessments, including all net income, gross income, sales
and use, ad valorem, transfer, gains, profits, excise,
franchise, real and personal property, gross receipt, capital
stock, production, business and occupation, disability, employment,
payroll, license, estimated, stamp, custom duties, severance or
withholding taxes or charges imposed by any Governmental Authority,
and includes any interest and penalties (civil or criminal) on or
additions to any such taxes and any expenses incurred in connection
with the determination, settlement or litigation of any tax
liability. “ Tax Return ”, as used in this
Agreement, means a report, return or other information required to
be supplied to a Governmental Authority with respect to Taxes
including, where permitted or required, combined or consolidated
returns for any group of entities.
(b) No Target Party
has taken or agreed to take any action that would prevent the
Merger from qualifying as a reorganization within the meaning of
Section 368(a) of the Code. Target is not aware of any
agreement, plan or other circumstance that would prevent the Merger
from qualifying as a reorganization within the meaning of
Section 368(a) of the Code.
(c) Each of the
Target Parties has duly and timely filed with the appropriate Tax
authorities or other Governmental Entities all Tax Returns required
to be filed. All such Tax Returns are complete and accurate in all
material respects. All Taxes shown as due on such Tax Returns have
been timely paid.
(d) The unpaid
Taxes of the Target Parties: (i) did not, as of the dates of
their respective most recent financial statements, exceed the
reserve for Tax liability (excluding any reserve for deferred Taxes
established to reflect timing differences between book and Tax
income) set forth on the face of the balance sheets contained in
such financial statements; and (ii) shall not exceed that
reserve as adjusted for operations and transactions through the
Closing Date in accordance with the past custom and practice of the
Target Parties in filing its Tax Returns.
(e) (i) No
deficiencies for Taxes with respect to any Target Party have been
claimed, proposed or assessed by a Tax authority or other
Governmental Authority; (ii) no audit or other proceeding for
or relating to any liability in respect of Taxes of any Target
Party is being conducted by any Tax authority or Governmental
Authority, and no Target Party has received notification in writing
that any such audit or other proceeding is pending; and
(iii) neither Target Party nor any predecessor has waived any
statute of limitations in respect of Taxes or agreed to any
extension of time with respect to a Tax assessment or
deficiency.
(f) There are no
Tax Liens upon any property or assets of any Target Party except:
(i) Liens for current Taxes not yet due and payable; and
(ii) Liens for Taxes that are being contested in good faith by
appropriate proceedings and for which adequate reserves are being
maintained in accordance with GAAP.
(g) Each Target
Party has withheld and paid all Taxes required to have been
withheld and paid in connection with amounts paid or owing to any
employee, independent contractor, creditor, shareholder, or other
third party.
(h) No Target Party
is currently the beneficiary of any extension of time within which
to file any material Tax Return.
(i) No claim has
ever been made with respect to a Target Party by an authority in a
jurisdiction where that Target Party does not file Tax Returns that
it is or may be subject to taxation by that
jurisdiction.
(j) No Target Party
has liability for the Taxes of any Person (other than members of
the affiliated group of which Target is the common parent):
(i) under Treasury Regulation Section 1.1502-6 (or any
similar provision of state, local, or foreign Law); (ii) as a
transferee or successor; (iii) by contract; or
(iv) otherwise.
(k) No Target Party
has been a United States real property holding corporation within
the meaning of Section 897(c)(2) of the Code during the
applicable period described in Section 897(c)(1)(A)(ii) of the
Code.
(l) No Target Party
has not been a party to any distribution occurring during the two
years preceding the date of this Agreement in which the parties to
such distribution treated the distribution as one to which
Section 355 of the Code is applicable.
(m) No Target Party
is a party to any Contract, plan or arrangement, under which it is
obligated to make or to provide, or could be become obligated to
make or to provide, a payment or benefit that would be
nondeductible under Section 280G of the Code.
(n) No Target Party
is a party to, bound by and does not have any obligation under any
Tax sharing, Tax allocation or Tax indemnity agreement or similar
contract or arrangement.
(o) No Target Party
(nor their respective Affiliates) has received any Tax Rulings (as
defined below) or entered into any Closing Agreements (as defined
below) with any Tax authority that would have a continuing material
adverse effect after the Effective Time. “ Tax Ruling
”, as used in this Agreement, shall mean a written ruling of
a taxing authority
relating to Taxes. “
Closing Agreement ”, as used in this Agreement, shall
mean a written and legally binding agreement with a taxing
authority relating to Taxes.
4.10
Reorganization Treatment .
(a) Assets .
At the Effective Time, Target will hold at least 90 percent of the
fair market value of its net assets and at least 70 percent of the
fair market value of its gross assets held immediately prior to the
Effective Time. For purposes of this representation, amounts paid
by the Surviving Corporation to holders of Target Dissenting Shares
and, pursuant to Section 2.1(g), holders of Target Stock and
amounts used by Target or the Surviving Corporation to pay Merger
expenses, in each case, will be treated as constituting assets of
Target immediately prior to the Effective Time.
(b) Business
. Each Target Party currently conducts a business. Such business is
such Target Party’s “historic business” within
the meaning of Treasury Regulations Section 1.368-1(d), and no
assets of such Target Party have been sold, transferred, or
otherwise disposed of that would prevent Alynx from continuing the
“historic business” of each Target Party or from using
a “significant portion” of each Target Party’s
“historic business assets” in a business following the
Merger, as such terms are used in Treasury Regulations
Section 1.368-1(d).
(c) Investment
Company . No Target Party is an “investment
company” as defined in Sections 368(a)(2)(F)(iii) and
(iv) of the Code.
(d) Redemptions
and Distributions . Neither Target nor any person related to
Target within the meaning of Treasury Regulations Sections
1.368-1(e)(3), (e)(4) and (e)(5) has purchased, redeemed or
otherwise acquired, or made any distributions with respect to, any
of Target’s stock prior to or in contemplation of the Merger,
or otherwise as part of a plan of which the Merger is a
part.
(e)
Dividends . At the Effective Time, there will be no accrued
but unpaid dividends on Target Stock.
(f) Control
. In the Merger, stock of Target representing “control”
of Target (within the meaning of Section 368(c) of the Code)
will be exchanged solely for “voting stock” of Alynx
(within the meaning of Sections 368(a)(1)(B) and (2)(E) of the
Code).
4.11
Environmental . To the Knowledge of Target, each Target
Party is in compliance in all material respects with all applicable
federal, state and local laws and regulations governing the
environment, public health and safety and employee health and
safety (including all provisions of the Occupational Safety and
Health Act (“ OSHA ”)) and no charge, complaint,
action, suit, proceeding, hearing, investigation, claim, demand or
notice has been filed or commenced against any Target Party and, to
the Knowledge of Target, no such charge, complaint, action, suit,
proceeding, hearing, investigation, claim, demand or notice is
pending or threatened in writing.
4.12
Litigation . There are no actions, suits, arbitrations,
regulatory proceedings or other litigation, proceedings or
governmental investigations pending or, to the Knowledge of Target,
threatened against any Target Party or any of their respective
officers or directors in their capacity as such, or any of their
respective properties or businesses, and Target has no Knowledge of
any
facts or circumstances which
may reasonably be likely to give rise to any of the foregoing. No
Target Party is subject to any order, judgment, decree, injunction,
stipulation or consent order of or with any court or other
Governmental Authority. No Target Party has entered into any
agreement to settle or compromise any proceeding pending or
threatened in writing against it which has involved any obligation
for which any Target Party has any continuing obligation. There are
no claims, actions, suits, proceedings, or investigations pending
or, to the Knowledge of Target, threatened by or against any Target
Party with respect to this Agreement or the Articles of Merger, or
in connection with the transactions contemplated hereby, and Target
has no reason to believe there is a valid basis for any such claim,
action, suit, proceeding or investigation.
4.13 Conflict of
Interest . Except as a holder of Target securities, to the
Knowledge of Target, no Person affiliated with any Target Party has
or will have any claims or rights with respect to any direct or
indirect interest in any tangible or intangible property used in
the business or operations of any Target Party.
4.14 Compliance
with Laws . No Target Party is subject to or in default of any
order of any court, Governmental Authority or other agency or
arbitration board or tribunal to which it is or was subject within
the past two years. No Target Party is in violation of any Laws
(including, but not limited to, those relating to environmental,
safety, building, product safety or health standards or labor or
employment matters) to which it is or was subject within the past
two years, except in each case as would not individually or in the
aggregate have a Target Material Adverse Effect. The businesses of
the Target Parties are currently being conducted, and at the
Closing Date will be conducted, in material compliance with
Applicable Law, except to the extent failure, individually or in
the aggregate, would not have a Target Material Adverse
Effect.
4.15 Broker
Fees . Except as disclosed on SCHEDULE 4.15 , no Target
Party has used any broker or finder in connection with the
transactions contemplated by this Agreement and, to the Knowledge
of Target, Alynx has not and will not have any liability or
otherwise suffer or incur any loss as a result of or in connection
with any brokerage or finder’s fee or other commission
payable as a result of any actions taken by the Target Parties with
respect to any broker or finder in connection with the Merger
contemplated by this Agreement.
4.16 Board
Approval . The Board of Directors of Target, at a meeting duly
called and held prior to execution of this Agreement, duly adopted
resolutions, unanimously approved by those directors present at
such meeting: (a) approving and declaring advisable this
Agreement, the Merger and the transactions contemplated hereby
(such approvals having been made in accordance with the Florida
Act); (b) determining that the terms of the Merger are fair to
and in the best interests of Target and its shareholders;
(c) recommending that the shareholders of Target approve and
adopt this Agreement and the Merger; and (d) adopting this
Agreement, which resolutions have not been modified, supplemented
or rescinded and remain in full force and effect.
4.17 Target
Party Disclosure Documents . The Target Party Disclosure
Documents have been delivered to Alynx. To the Knowledge of Target,
as of their respective dates, the Target Party Disclosure Documents
did not contain a misstatement of a material fact o
|